Generally, companies and individuals that are involved in FDA regulated industries are quite familiar with and concerned about FDA regulations and enforcement. However, not all of these companies and individuals may be as familiar with advertising law and enforcement by the Federal Trade Commission (FTC), despite the fact that their products are also subject to FTC jurisdiction and the FTC continues to pursue enforcement actions, often involving large monetary payments, under the Lanham Act against individuals and companies involved in advertising FDA-regulated products such as dietary supplements, foods, and cosmetics.
In this live audio conference, expert speaker Cynthia Meyers will provide an overview of basic advertising law concepts, including claim substantiation, endorsements, adequate disclosures, native advertising, and puffery. She will also discuss specific claims such as comparative, “Made in the USA,” and environment-friendly claims, and will also include discussion of the self-regulatory body, the National Advertising Division (NAD). Cynthia will touch upon particular areas that are especially relevant for many in FDA-regulated industries.
The focus of the session is on how these concepts are particularly relevant to FDA-regulated industries. For example, when creating claims for dietary supplement products, companies must consider not only the FDA perspective (e.g., are the claims disease claims or structure/function claims?) but also the advertising law/FTC perspective (e.g., is there support for the claims?). Claims for cosmetic products such as anti-wrinkle creams must both avoid being drug claims (FDA perspective) and must not be false or misleading by implying better results than can be supported (advertising law/FTC perspective).
What can be difficult is that the concerns from an FDA perspective and from an advertising law/FTC perspective may not overlap so well. Compliance from one perspective does not mean compliance from the other perspective, and in some cases, it may not be possible to find a commercially-desirable solution that can be compliant from both perspectives.
Additionally, if time permits, the session will also touch upon social media and native advertising concerns from an advertising law perspective.
Who should attend
This training will be useful for individuals and companies involved in marketing, advertising, or developing products regulated by the FDA, such as:
Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.
- Dr. David Lim
Cynthia Meyer is an associate at Kleinfeld, Kaplan, and Becker, LLP, a boutique food and drug law firm in Washington, DC. Her practice focuses primarily on counseling and advocating on behalf of companies and individuals in the pharmaceutical, medical device, food, cosmetic, dietary supplement, and alcoholic beverage industries on legal and regulatory matters involving the FDA, USDA, FTC, TTB, and other related federal and state agencies.
More Events By The Speaker